Target type: cellularcomponent
An integrin complex that comprises one alphav subunit and one beta8 subunit. [PMID:12297042]
The integrin alphav-beta8 complex is a transmembrane receptor that plays a crucial role in cell adhesion, migration, and signaling. It is a heterodimer composed of two subunits: alphav and beta8. The alphav subunit is a type II transmembrane protein with a large extracellular domain that contains multiple ligand-binding sites. The beta8 subunit is a type I transmembrane protein with a smaller extracellular domain.
The extracellular domains of both alphav and beta8 subunits contribute to the formation of the ligand-binding site, which is located at the interface between the two subunits. This site recognizes and binds to a variety of extracellular matrix (ECM) proteins, including vitronectin, fibronectin, and laminin.
The integrin alphav-beta8 complex is localized to the cell surface, where it interacts with the ECM. This interaction is essential for cell adhesion and migration, as it provides a stable anchor for cells to attach to the surrounding matrix. The complex also plays a role in cell signaling, as it can transduce signals from the ECM into the cell, triggering a variety of intracellular signaling pathways.
Specifically, the cellular component of the integrin alphav-beta8 complex can be described as follows:
- **Plasma membrane:** The integrin alphav-beta8 complex is a transmembrane protein and therefore resides in the plasma membrane. This is the outer boundary of the cell, which separates the cell's interior from the external environment.
- **Focal adhesions:** The integrin alphav-beta8 complex is concentrated in focal adhesions, which are specialized structures that connect the cytoskeleton to the ECM. Focal adhesions are dynamic structures that undergo constant assembly and disassembly in response to changes in cell shape, migration, and adhesion.
- **Cytoskeleton:** The integrin alphav-beta8 complex interacts with the cytoskeleton, which is a network of protein filaments that provide structural support and facilitate cell movement. The complex can bind to cytoskeletal proteins such as actin and talin, linking the ECM to the intracellular environment.
- **Signaling pathways:** The integrin alphav-beta8 complex participates in a variety of signaling pathways, including the focal adhesion kinase (FAK) pathway, the Ras pathway, and the Rho GTPase pathway. These pathways regulate cell adhesion, migration, proliferation, and survival.
Overall, the cellular component of the integrin alphav-beta8 complex encompasses the plasma membrane, focal adhesions, cytoskeleton, and signaling pathways. It plays a crucial role in mediating cell adhesion, migration, and signaling, and its dysfunction can contribute to various disease states.'
"
Protein | Definition | Taxonomy |
---|---|---|
Integrin alpha-V | An integrin alpha-V that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06756] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
1-(3-chlorophenyl)biguanide | 1-(3-chlorophenyl)biguanide: RN given refers to parent cp; a 5-HT3 receptor agonist | biguanides; monochlorobenzenes | |
phenyl biguanide | phenyl biguanide : A member of the class of biguanides that is biguanide in which one of the terminal nitrogen atoms is substituted by a phenyl group. phenyl biguanide: RN given refers to parent cpd | guanidines | central nervous system drug |
4-chlorophenylbiguanide | |||
paclitaxel | Taxus: Genus of coniferous yew trees or shrubs, several species of which have medicinal uses. Notable is the Pacific yew, Taxus brevifolia, which is used to make the anti-neoplastic drug taxol (PACLITAXEL). | taxane diterpenoid; tetracyclic diterpenoid | antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent |
tirofiban | tirofiban : A member of the class of piperidines that is L-tyrosine in which a hydrogen attached to the amino group is replaced by a butylsulfonyl group and in which the hydrogen attached to the phenolic hydroxy group is replaced by a 4-(piperidin-4-yl)butyl group. Tirofiban: Tyrosine analog and PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX antagonist that inhibits PLATELET AGGREGATION and is used in the treatment of ACUTE CORONARY SYNDROME. | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
25-hydroxycholesterol | 25-hydroxy steroid; oxysterol | human metabolite | |
tetraiodothyroacetic acid | 3,3',5,5'-tetraiodothyroacetic acid : A monocarboxylic acid that is thyroacetic acid carrying four iodo substituents at positions 3, 3', 5 and 5'. tetraiodothyroacetic acid: RN given refers to parent cpd; structure | 2-halophenol; aromatic ether; iodophenol; monocarboxylic acid | apoptosis inducer; human metabolite; thyroid hormone |
arginyl-glycyl-aspartic acid | arginyl-glycyl-aspartic acid: amino acid sequence of basic unit of widespread cellular recognition system | oligopeptide | |
glycyl-arginyl-glycyl-aspartyl-serine | glycyl-arginyl-glycyl-aspartyl-serine: synthetic peptide from fibronectins; inhibits experimental metastasis of murine melanoma cells | ||
glycyl- arginyl-glycyl-aspartyl-seryl-prolyl-lysine | |||
d-arg-gly-asp-trp | arginyl-glycyl-aspartyl-tryptophan: a synthetic RGD-containing peptide | ||
l 738167 | L 738167: structure in first source | ||
sk&f 107260 | SK&F 107260: structure given in first source | ||
cilengitide | Cilengitide: an alphaVbeta3 integrin antagonist that paralyzes cancer cells | oligopeptide | |
l 734217 | L 734217: fibrinogen receptor antagonist; structure given in first source | ||
elarofiban | elarofiban: a GPIIb and GPIIIa receptor antagonist; structure in first source | ||
eptifibatide | homodetic cyclic peptide; macrocycle; organic disulfide | anticoagulant; platelet aggregation inhibitor | |
arginyl-glycyl-aspartyl-phenylalanine | |||
sb 223245 | |||
cyclic(arg-gly-asp-d-phe-val) | |||
mk-0429 | |||
sb 273005 |